Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: A review of short-term studies with three dose regimens of latanoprost treatment

Survey of Ophthalmology

Volumn 41, Issue SUPPL. 2, 1997, Pages

  Greve, E L ^a   Rulo, A H ^a   Drance, S M ^a   Crichton, A C ^a   Mills, R P ^a   Hoyng, P F J ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

blood pressure; intraocular pressure reduction; latanoprost; normal tension glaucoma; ocular perfusion pressure; prostaglandin; timolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EYE DROPS; LATANOPROST; PILOCARPINE; PLACEBO; PROSTAGLANDIN F2 ALPHA DERIVATIVE; TIMOLOL;

AQUEOUS HUMOR OUTFLOW; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EYE BLOOD FLOW; GLAUCOMA; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; PERFUSION PRESSURE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VISUAL FIELD DEFECT;

EID: 0030906586     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0039-6257(97)80013-6     Document Type: Conference Paper

References (18)

1. A Ahn I Widengård D Kjellgren Latanoprost administered once daily caused a maintained reduction ofintraocular pressure in glaucoma patients treated concomitantly with timolol BrJ Ophthalmol 79 1995 12 16
2. A Alm CB Camras P Watson Phase 3 latanoprost studies: Masked 6-month comparisons with timolol, in the United Kingdom, Scandinavia and USA Surv Ophthalmol 41 Suppl 2 1997 S105 S110
3. RF Brubaker Flow of aqueous humor in humans Invest Ophthalmol Vis Sci 32 1991 3145 3166
4. N de Jong EL Greve PF Hoyng HC Geijssen Results of a filtering procedure in low tension glaucoma Int Ophthalmol 13 1989 131 138
5. HC Geijssen Study on Normal Pressure Glaucoma (Thesis) 1991 Kugler Amstelveen 218 219
6. SL Graham SM Drance K Wijsman Nocturnal hypotension in glaucoma patients (abstract) Invest Ophthalmol Vis Sci 34 Suppl 1993 1286
7. SS Hayreh Progress in the understanding of the vascular etiology of glaucoma Curr Opin Ophthahnol 5 1994 26 35
8. 2α lowers intraocular pressure Prog Clin Biol Res 312 1989 387 416
9. D Kjellgren G Douglas FS Mikelberg The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma Acta Ophthahnol Scand 73 1995 233 236
10. HK Mishima Y Kiuchi M Takamatsu Circadian intraocular pressure management with 0.005% topical latanoprost: Diurnal and nocturnal IOP reduction and increased uveoscleral outflow Surv Ophthalmol 41 Suppl 2 1997 S139 S144
11. S Nagasubramanian GP Sheth RA Hitchings J Stjernschantz Intraocular pressure-reducing effect of PhXA41 in ocular hypertension Ophthalmology 100 1993 1305 1311
12. P Racz MR Ruzsonyi ZT Nagy Around-the-clock (circadian) intraocular pressure reduction with once-daily application of latanoprost, by itself or in combination with timolol Arch Ophthalmol 114 1996 268 273
13. GR Reiss DA Lee J Topper RF Brubaker Aqueous humor flow during sleep Invest Ophthalmol Vis Sci 25 1984 776 778
14. AH Rulo EL Greve HC Geyssen PFJ Hoyng Reduction of intraocular pressure with treatment of latanoprost once daily in normal pressure glaucoma patients Ophthalmology 103 1996 1276 1282
15. M Schulzer Intraocular pressure reduction in normal-tension glaucoma patients The normal tension glaucoma study group. Ophthalmology 99 1992 1468 1470
16. JM Tielsch J Katz A Sommer H Quigley JC Javitt Hypertension, perfusion pressure and primary open angle glaucoma Arch Ophthalmol 113 1995 216 221
17. JE Topper RF Brubaker Effects oftimolol, epinephrine, and acetazolamide on aqueous flow during sleep Invest Ophthahnol Vis Sci 26 1985 1315 1319
18. CB Toris ME Yablonski CB Camras RF Brubaker Mechanism of the ocular hypotensive effect of latanoprost and the maintenance of normal blood-aqueous barrier function Surv Ophthalmol 41 Suppl 2 1997 S69 S75